Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KHK | P50053 | 3/20 | 0.37 |
| ▸ | MET | P08581 | 3/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 3/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 6/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23836949 | 0.94 | MET (0.40) | KHKMETLRRK2 | |
| SCHEMBL23836963 | 0.92 | MET (0.41) | KHKMETMAP4K4P2RX7 | |
| SCHEMBL22013656 | 0.92 | CHRNA4 (0.40) | KHKMETLRRK2 | |
| SCHEMBL23837041 | 0.90 | MAP4K4 (0.36) | KHKMETMAP4K4LRRK2 | |
| SCHEMBL23836974 | 0.90 | MAP4K4 (0.36) | KHKMETMAP4K4LRRK2 | |
| SCHEMBL22014126 | 0.89 | KHK (0.39) | KHKMAP4K4P2RX7LRRK2 | |
| SCHEMBL23836989 | 0.88 | MELK (0.41) | METMAP4K4LRRK2 | |
| SCHEMBL23837009 | 0.86 | P2RX7 (0.39) | MAP4K4P2RX7LRRK2 | |
| SCHEMBL23837050 | 0.86 | P2RX7 (0.39) | MAP4K4P2RX7LRRK2 | |
| SCHEMBL23837042 | 0.86 | MAP4K4 (0.34) | MAP4K4P2RX7LRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882247-A1 | SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR | Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) | 2021-09-22 | — | — | EP | disclosed |
| WO-2020098723-A1 | SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR | 上海轶诺药业有限公司 | 2020-05-22 | — | — | WO | disclosed |